Document is current
Any future updates will be listed below
-
Authors
van Koll, Johan
Engels, Madelon D. E. A.
Rijks, Jesse H. J.
Salari, Madelon
Luijten, Jelle
Lumens, Joost
van Empel, Vanessa P. M.
Westra, Sjoerd W.
van Stipdonk, Antonius M. W.
Lankveld, Theo A. R.
Chaldoupi, Sevasti M.
Joza, Jacqueline
Beukema, Rypko J.
Luermans, Justin G. L. M.
Linz, Dominik K.
Vernooy, Kevin https://orcid.org/0000-0002-8818-5964
- License Information
-
More Information
Article History
Received: 14 January 2025
Accepted: 26 March 2025
First Online: 7 April 2025
Declarations
:
: J.v.K., M.E., J.R., M.S., S.W., A.S., T.L., R.B., D.L..: no conflicts to disclose; Jo.L. has a consultancy agreement with Medtronic (fees paid to institute); Jo.L. has received research grants from Medtronic (grants paid to institute); V.v.E. receives consultancy fees from Novartis, Janssen, Boehringer Ingelheim, Novonordisk (paid to institute) and received sponsoring/grants from Roche, Vifor Pharma, Boehringer Ingelheim, Astra Zeneca and Pfizer (paid to institute and not related to submitted work); J.J. has a research grant from Medtronic, consultant for Boston Scientific, Abbott, Medtronic; S.C. has a research grant and consultancy agreement with Biosense webster (paid to the institute). J.L. has a consultancy agreement and research grant from Medtronic, consultant for Abbott (all paid to the institute). KV: has research and educational grants and consultancy agreements with Medtronic, Abbott, Boston scientific, Philips and Biosense webster (all grants are paid to the institute).
